Revolutionizing Multiple Myeloma Treatment: The Potential of New Drug Classes
The treatment landscape for multiple myeloma has made tremendous strides in recent years, largely due to the emergence of innovative therapies like bispecific antibodies and CAR T (chimeric antigen receptor T-cell) therapies.
